Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

RekryterarObservationsstudieFriska volontärer välkomna

Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Hematology Oncology Associates of CNY at Camillus, Camillus
Memorial Sloan Kettering Commack, Commack
Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
och 10 fler

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT04269902

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, New York
Research Site, New York

RekryterarFas 1/2

Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06542250

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Memorial Sloan Kettering Cancer Center Mskcc, New York
New York Cancer and Blood Specialists, Shirley
Optum Medical Care, Pc, Westbury

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06846671

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Columbia University Medical Center, New York

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07277231

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Memorial Sloan Kettering Cancer Center Mskcc, New York
Optum Medical Care, Pc, Westbury

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06943872

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Columbia University Medical Center, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center Mskcc, New York
och 1 fler

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06973187

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

New York Oncology Hematology, P.C. ( Site 0069), Albany
Roswell Park Cancer Institute ( Site 0023), Buffalo
RPCI Oncology, PC- Northtowns ( Site 0061), Williamsville

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06136559

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Cayuga Cancer Center, Ithaca
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York

RekryterarFas 4

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07218341

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

David H. Koch Center for Cancer Care, New York
Montefiore Medical Center PRIME, The Bronx

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07648264

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Research Site, New York

RekryterarFas 1/2

Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06564038

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT03666000

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT06849713

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

RekryterarFas 1/2

Ålder 13 till 90 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06533579

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

University of Rochester NCORP Research Base, Rochester

RekryterarObservationsstudieFriska volontärer välkomna

Ålder 18 och äldre · Alla kön · Uppdaterad 10 juni 2026 · NCT07638007

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Icahn School of Medicine at Mount Sinai /ID# 266328, New York

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT06428019

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT07218510

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Cayuga Cancer Center, Ithaca
Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
och 2 fler

RekryterarFas 4

Ålder 18 och äldre · Alla kön · Uppdaterad 2 mars 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York

RekryterarFas 4

Ålder 18 och äldre · Alla kön · Uppdaterad 2 mars 2026 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

Roswell Park Comprehensive Cancer Center, Buffalo
Weill Cornell, New York
Montefiore Medical Center, The Bronx

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 13 feb. 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Optum Medical Care PC, Westbury

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 10 dec. 2025 · NCT05602363

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Northwell (Northshore University/Long Island Jewish Hospitals), New Hyde Park

Rekryterar

Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2025 · NCT05643235

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.